Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 13.2B | 11.1B | 9.0B | 11.1B |
Cost of revenue | 7.4B | 6.2B | 3.6B | 5.2B |
Gross profit | 5.8B | 4.9B | 5.4B | 5.8B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 3.7B | 3.3B | 3.1B | 3.3B |
Operating income | 211.8M | -217.6M | 490.1M | 756M |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 523.9M | 539.4M | 572.4M | 525.5M |
Other income expense | — | — | — | — |
Pretax income | 308.4M | -646.4M | 50.5M | 340.6M |
Tax provision | 87.1M | -217.5M | 24.6M | 121.5M |
Net income | 221.3M | -428.9M | 25.9M | 219.1M |
Basic EPS | — | -6.2 | 0.4 | 3.2 |
Diluted EPS | — | -6.2 | 0.4 | 3.2 |
Basic average shares | — | 69.2M | 70M | 69.1M |
Diluted average shares | — | 69.2M | 70M | 69.1M |
EBITDA | 1.6B | 657.5M | 1.4B | 1.6B |
Net income from continuing op. | — | — | — | — |
Minority interests | — | — | — | — |
Preferred stock dividends | 0 | 0 | 0 | 0 |